INZY•benzinga•
Jefferies Downgrades Inozyme Pharma to Hold, Lowers Price Target to $4
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 16, 2025 by benzinga